Be SMART NIS, Moderate to Servere Asthma Patient Observation

AstraZeneca

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT00514787

NIS-RAT-SYM-2007/1

Details and patient eligibility

About

Screen for moderate to severe asthma patients with suboptimal asthma control (as defined by GINA-Guidelines). Document current asthma control status. Re-evaluate asthma therapy and document new therapy if applicable.

Enrollment: 900 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Moderate to severe asthma with suboptimal control

Exclusion criteria

• Intermittent or mild asthma, patient with good asthma control